These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9213377)

  • 41. Eosinophilia-myalgia syndrome due to L-tryptophan ingestion. Report of four cases and review of the Maryland experience.
    Roubenoff R; Coté T; Watson R; Levin ML; Hochberg MC
    Arthritis Rheum; 1990 Jul; 33(7):930-8. PubMed ID: 2369429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
    Beko E; Pervaiz S; Nanda V; Dhawan S
    Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
    Terao T; Hori H; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):650-3. PubMed ID: 10434740
    [No Abstract]   [Full Text] [Related]  

  • 44. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
    Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
    Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eosinophilia-myalgia syndrome: coming to grips with a new illness.
    Kilbourne EM
    Epidemiol Rev; 1992; 14():16-36. PubMed ID: 1289111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities.
    Kaufman LD; Varga J; Gomez-Reino JJ; Jimenez S; Targoff IN
    Clin Immunol Immunopathol; 1995 Aug; 76(2):115-9. PubMed ID: 7542184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.
    Hill RH; Caudill SP; Philen RM; Bailey SL; Flanders WD; Driskell WJ; Kamb ML; Needham LL; Sampson EJ
    Arch Environ Contam Toxicol; 1993 Jul; 25(1):134-42. PubMed ID: 8346973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
    Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
    J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
    Varga J; Maul GG; Jimenez SA
    Arthritis Rheum; 1992 Jan; 35(1):106-9. PubMed ID: 1290474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
    Zangrilli JG; Mayeno AN; Vining V; Varga J
    Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome.
    Williamson BL; Tomlinson AJ; Hurth KM; Posada de la Paz M; Gleich GJ; Naylor S
    Biomed Chromatogr; 1998; 12(5):255-61. PubMed ID: 9787895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A diagnostic algorithm for distinguishing the eosinophilia-myalgia syndrome from fibromyalgia and chronic myofascial pain.
    Taylor RM; Gabriel SE; O'Fallon WM; Bowles CA; Duffy J
    J Rheumatol Suppl; 1996 Oct; 46():13-8. PubMed ID: 8895177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements.
    Clauw DJ; Flockhart DA; Mullins W; Katz P; Medsger TA
    J Rheumatol; 1994 Dec; 21(12):2385-7. PubMed ID: 7699648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.
    Krupp LB; Masur DM; Kaufman LD
    Neurology; 1993 May; 43(5):931-6. PubMed ID: 8492948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Eosinophilia-myalgia syndrome. The clinical spectrum expands].
    Schnabel A; Gross WL
    Z Rheumatol; 1992; 51(1):1-2. PubMed ID: 1574930
    [No Abstract]   [Full Text] [Related]  

  • 57. Continuing occurrence of eosinophilia myalgia syndrome in Canada.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Faith JM; Elmore JG; Horwitz RI
    Br J Rheumatol; 1995 Mar; 34(3):246-51. PubMed ID: 7728400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Two cases of L-tryptophan ingestion induced eosinophilia-myalgia syndrome].
    Mizutani T; Mizutani H; Hashimoto K; Kishida M; Taniguchi H; Okada H; Murata M; Nakamura Y; Shimizu M
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):561-6. PubMed ID: 1890752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].
    Grangeia Tde A; Schweller M; Paschoal IA; Zambon L; Pereira MC
    J Bras Pneumol; 2007; 33(6):747-51. PubMed ID: 18200378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.